These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32222156)

  • 1. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
    Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
    Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin induces
    Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants.
    Mosallaei D; Hao M; Antaya RJ; Levian B; Kwong A; Cogan J; Hamilton C; Schwieger-Briel A; Tan C; Tang X; Woodley DT; Chen M
    JAMA Dermatol; 2022 Apr; 158(4):366-374. PubMed ID: 35234826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Woodley DT; Hao M; Kwong A; Levian B; Cogan J; Hou Y; Mosallaei D; Kleinman E; Zheng K; Chung C; Kim G; Peng D; Chen M
    Br J Dermatol; 2024 Jul; 191(2):267-274. PubMed ID: 38366625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa.
    Levian B; Hou Y; Tang X; Bainvoll L; Zheng K; Badarinarayana V; Aghamohammadzadeh S; Chen M
    Mol Ther Nucleic Acids; 2024 Dec; 35(4):102334. PubMed ID: 39391765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
    Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
    J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of Severe Generalized Junctional Epidermolysis Bullosa by Systemic Treatment with Gentamicin.
    Hammersen J; Neuner A; Wild F; Schneider H
    Dermatology; 2019; 235(4):315-322. PubMed ID: 31132778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa.
    Jeon IK; Kim SE; Kim SC
    J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.
    Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J
    Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.
    Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D
    J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical gentamicin ointment induces LAMB3 nonsense mutation readthrough and improves corneal erosions in a patient with junctional epidermolysis bullosa.
    Hung JH; Hou PC; Huang FC; Hsu CK
    Clin Exp Ophthalmol; 2021 Apr; 49(3):309-312. PubMed ID: 33634938
    [No Abstract]   [Full Text] [Related]  

  • 12. Laminin 332 in junctional epidermolysis bullosa.
    Kiritsi D; Has C; Bruckner-Tuderman L
    Cell Adh Migr; 2013; 7(1):135-41. PubMed ID: 23076207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa.
    Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G
    Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carriers with functional null mutations in LAMA3 have localized enamel abnormalities due to haploinsufficiency.
    Gostyńska KB; Yan Yuen W; Pasmooij AMG; Stellingsma C; Pas HH; Lemmink H; Jonkman MF
    Eur J Hum Genet; 2016 Jan; 25(1):94-99. PubMed ID: 27827380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herlitz junctional epidermolysis bullosa.
    Laimer M; Lanschuetzer CM; Diem A; Bauer JW
    Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging.
    Gache Y; Allegra M; Bodemer C; Pisani-Spadafora A; de Prost Y; Ortonne JP; Meneguzzi G
    Hum Mol Genet; 2001 Oct; 10(21):2453-61. PubMed ID: 11689492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands.
    Yuen WY; Lemmink HH; van Dijk-Bos KK; Sinke RJ; Jonkman MF
    Br J Dermatol; 2011 Dec; 165(6):1314-22. PubMed ID: 21801158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel LAMA3 mutation in a newborn with junctional epidermolysis bullosa herlitz type.
    Mazzucchelli I; Garofoli F; Decembrino L; Castiglia D; Tadini G; Bellingeri A; Borghesi A; Tzialla C; Manzoni P; Stronati M
    Neonatology; 2011; 99(3):188-91. PubMed ID: 20881434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes.
    Nakano A; Chao SC; Pulkkinen L; Murrell D; Bruckner-Tuderman L; Pfendner E; Uitto J
    Hum Genet; 2002 Jan; 110(1):41-51. PubMed ID: 11810295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.
    Keith AR; Twaroski K; Ebens CL; Tolar J
    Expert Opin Biol Ther; 2020 Aug; 20(8):911-923. PubMed ID: 32178539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.